DBV Technologies | DBVT - 부채





부채 변화 날짜
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
DBV Technologies USD 6.1M 2.49M 2026-03
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Incyte USD 38.27M 1.16M 2026-06
Insmed USD 725.8M 1.82M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
United Therapeutics USD 200M 100M 2025-03